INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1346651718-decentralized-doctor-patient-computer-remote]( "Patient Trust And Engagement In The Age Of Decentralized Trials")
Patient Trust And Engagement In The Age Of Decentralized TrialsTo truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
![Clinical Leader Solutions Expo]( "Running Flexible Trials In The Heart Of Patient Communities")
Running Flexible Trials In The Heart Of Patient CommunitiesBringing clinical research closer to patients by running flexible trials in the heart of their own communities increases access to research for both patients and sites.
-
![doctor with adult female patient-GettyImages-1661446453]( "Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment")
Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial RecruitmentExplore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.
-
![GettyImages-2148853397-whiteboard-people-strategy-thinking-writing-ipad]( "The Path Forward In Oncology Trials")
The Path Forward In Oncology TrialsA comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting10/30/2024
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
Why Should Site Agility Be Your Next Competitive Advantage?1/26/2026
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
-
Strategies For Biomarker Development And Early Phase Clinical Studies5/2/2025
Companion diagnostics (CDx) are crucial for personalized medicine to enable precise patient selection for therapies. Explore biomarker development strategies and early-phase study considerations.
-
The Importance Of Diversity In Clinical Trials10/16/2024
A recent FDA draft guidance aims to address health disparities and enhance data quality with action plans for greater inclusivity in clinical trials. Explore practical steps to building trust and inclusivity in clinical research.
-
You're Buying Patient And Site Services All Wrong12/5/2025
Centralize patient and site services under a single platform to streamline operations, reduce costs, and deliver a consistent, patient-focused experience that enhances trial performance.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-638646884 medical team meeting]( "Rethinking Lab Logistics: Delivering The Complex Without Compromise")
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
-
![Medical data iStock-1210343139]( "Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility")
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
![GettyImages-1311977468 site payments]( "Greenphire Patient Payments")
esigned for sponsors, CROs, sites, and patients, this modern solution delivers real-time data that supports crucial decisions during investigator grant budgeting, randomization, patient payments, and endpoint collection.
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
![microplate panel for diseases diagnosis GettyImages-1387090964]( "Bringing Endocrine And Metabolic Disease Treatments To Market")
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
